Institutional Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $15.3M | Sell |
421,073
-251,310
| -37% | -$9.11M | 0.23% | 47 |
|
|
2016
Q3 | $45.6M | Sell |
672,383
-4,150,176
| -86% | -$282M | 0.63% | 40 |
|
|
2016
Q2 | $242M | Sell |
4,822,559
-487,675
| -9% | -$24.5M | 2.97% | 14 |
|
|
2016
Q1 | $284M | Buy |
5,310,234
+212,242
| +4% | +$11.4M | 3.02% | 18 |
|
|
2015
Q4 | $335M | Buy |
5,097,992
+4,361,352
| +592% | +$286M | 2.9% | 17 |
|
|
2015
Q3 | $41.6M | Buy |
+736,640
| New | +$41.6M | 0.35% | 44 |
|
|
2013
Q4 | – | Sell |
-2,245,550
| Closed | -$84.8M | – | 48 |
|
|
2013
Q3 | $84.8M | Buy |
2,245,550
+1,013,350
| +82% | +$38.3M | 0.43% | 40 |
|
|
2013
Q2 | $48.3M | Buy |
+1,232,200
| New | +$48.3M | 0.25% | 41 |
|